We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-based Software Analyzes Cancer Cells from Digitized Pathology Slides to Improve Diagnoses

By LabMedica International staff writers
Posted on 31 Dec 2019
Researchers from UT Southwestern (Dallas, TX, USA) have developed a software tool that uses artificial intelligence (AI) to recognize cancer cells from digital pathology images, allowing clinicians to predict patient outcomes.

The spatial distribution of different types of cells can reveal a cancer’s growth pattern, its relationship with the surrounding microenvironment, and the body’s immune response. More...
However, the process of manually identifying all the cells in a pathology slide is extremely labor intensive and error-prone. A major technical challenge in systematically studying the tumor microenvironment is how to automatically classify different types of cells and quantify their spatial distributions.

The AI algorithm, called ConvPath, developed by the researchers overcomes these obstacles by using AI to classify cell types from lung cancer pathology images. The ConvPath algorithm can “look” at cells and identify their types based on their appearance in the pathology images using an AI algorithm that learns from human pathologists. The algorithm effectively converts a pathology image into a “map” that displays the spatial distributions and interactions of tumor cells, stromal cells (i.e., the connective tissue cells), and lymphocytes (i.e., the white blood cells) in tumor tissue. Whether tumor cells cluster well together or spread into stromal lymph nodes is a factor revealing the body’s immune response. So knowing that information can help doctors customize treatment plans and pinpoint the right immunotherapy. Ultimately, the algorithm helps pathologists obtain the most accurate cancer cell analysis – in a much faster way.

“As there are usually millions of cells in a tissue sample, a pathologist can only analyze so many slides in a day. To make a diagnosis, pathologists usually only examine several ‘representative’ regions in detail, rather than the whole slide. However, some important details could be missed by this approach,” said Dr. Guanghua “Andy” Xiao, corresponding author of a study published in EBioMedicine and Professor of Population and Data Sciences at UT Southwestern. “It is time-consuming and difficult for pathologists to locate very small tumor regions in tissue images, so this could greatly reduce the time that pathologists need to spend on each image.”

Related Links:
UT Southwestern


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.